Acutus Medical Statistics
Total Valuation
Acutus Medical has a market cap or net worth of 1.56 million. The enterprise value is 24.74 million.
| Market Cap | 1.56M |
| Enterprise Value | 24.74M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Acutus Medical has 29.91 million shares outstanding. The number of shares has increased by 2.13% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 29.91M |
| Shares Change (YoY) | +2.13% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 10.14% |
| Owned by Institutions (%) | 0.01% |
| Float | 24.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.59 |
| EV / Sales | 1.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.55 |
Financial Position
The company has a current ratio of 1.85
| Current Ratio | 1.85 |
| Quick Ratio | 1.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.80 |
| Interest Coverage | -2.24 |
Financial Efficiency
Return on equity (ROE) is -49.22% and return on invested capital (ROIC) is -17.28%.
| Return on Equity (ROE) | -49.22% |
| Return on Assets (ROA) | -14.21% |
| Return on Capital (ROIC) | -17.28% |
| Revenue Per Employee | 66,272 |
| Profits Per Employee | -180,629 |
| Employee Count | 233 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.82% in the last 52 weeks. The beta is 0.15, so Acutus Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -70.82% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 43.51 |
| Average Volume (20 Days) | 62,182 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Acutus Medical had revenue of 15.38 million and -41.91 million in losses. Loss per share was -1.41.
| Revenue | 15.38M |
| Gross Profit | -110,000 |
| Operating Income | -13.28M |
| Pretax Income | -5.21M |
| Net Income | -41.91M |
| EBITDA | -13.24M |
| EBIT | -13.28M |
| Loss Per Share | -1.41 |
Balance Sheet
The company has 12.60 million in cash and 35.78 million in debt, giving a net cash position of -23.19 million or -0.78 per share.
| Cash & Cash Equivalents | 12.60M |
| Total Debt | 35.78M |
| Net Cash | -23.19M |
| Net Cash Per Share | -0.78 |
| Equity (Book Value) | -10.30M |
| Book Value Per Share | -0.34 |
| Working Capital | 12.49M |
Cash Flow
In the last 12 months, operating cash flow was -45.62 million and capital expenditures 820,000, giving a free cash flow of -44.80 million.
| Operating Cash Flow | -45.62M |
| Capital Expenditures | 820,000 |
| Free Cash Flow | -44.80M |
| FCF Per Share | -1.50 |
Margins
Gross margin is -0.72%, with operating and profit margins of -86.40% and -272.56%.
| Gross Margin | -0.72% |
| Operating Margin | -86.40% |
| Pretax Margin | -33.85% |
| Profit Margin | -272.56% |
| EBITDA Margin | -86.13% |
| EBIT Margin | -86.40% |
| FCF Margin | n/a |
Dividends & Yields
Acutus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.13% |
| Shareholder Yield | -2.13% |
| Earnings Yield | -2,718.22% |
| FCF Yield | -2,879.89% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Acutus Medical has an Altman Z-Score of -26.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.81 |
| Piotroski F-Score | n/a |